Official publication of Rawalpindi Medical University
Clinicopathological features of different Histopathological Subtypes and Stages of Wilms Tumor

Supplementary Files

PDF

Keywords

Wilms tumor (WT), Internal Society of Pediatric Oncology (SIOP 2001), Post chemotherapy.

How to Cite

1.
Ahmad A, Anjum A, Hashim I, Hussain M, Zaman S, Sahrish F. Clinicopathological features of different Histopathological Subtypes and Stages of Wilms Tumor . JRMC [Internet]. 2023 Apr. 1 [cited 2024 Jun. 15];27(1). Available from: http://www.journalrmc.com/index.php/JRMC/article/view/2040

Abstract

Introduction: Wilms tumor is the most common pediatric renal neoplasm. Following preoperative therapy, various histological subtypes, risks and clinical stages are determined as per following SIOP 2001 protocol. To determine the clinicopathological features of different histopathological subtypes and stages of Wilms tumor after completing course of preoperative as well as postoperative chemotherapy following SIOP 2001 protocol.

Methodology: This is a retrospective cross-sectional study and sample size calculated by non-probability technique. Ninety-three patients with abdominal masses in the Hematology/Oncology Department were included. After radiological and histopathological diagnosis, four weeks of preoperative chemotherapy, given to patients, followed by partial and radical nephrectomies by surgical team. Specimens received in Histopathology Department grossed and microscopically examined for different post chemotherapy histological subtypes. Further risk categorization and clinicopathological staging in accordance with SIOP 2001, done after completion of treatment. Patients called for yearly follow up for the next five years. Categorical variables are presented as frequencies and percentages.

Results: Mean age of ninety-three children was 44.4 months + 30.92with predominance of males (55.9%) and more common in right sided kidney (55.9%). Majority patients completed the entire course of treatment (77.4%). Majority were intermediate risk tumors (76.3%) and most common histological subtype was Mixed Tumor subtype (23.4%). In our study majority, tumors were stage III (48.3%) and patients died due to febrile neutropenia (9.6%)

Conclusion: In our study the majority of patients completed the entire course of treatment and relapse was fairly less. Patients lost to follow up after nephrectomy and deaths at home caused by febrile neutropenia were our major challenges.

 

https://doi.org/10.37939/jrmc.v27i1.2040

References

Cunningham ME, Klug TD and Nuchtern JG. Global disparities in Wilms tumor. Journal of surgical research. 2020 Mar 1; 247:34-51. https://doi.org/10.1016/j.jss.2019.10.044

Friedman AD. Wilms tumor Pediatrics in Review 2013;34(7):328-30

Maciaszek JL, Oak N and Nichols KE. Recent advances in Wilms’ tumor predisposition. Human molecular genetics. 2020 Oct 1; 29(R2):R138-49. https://doi.org/10.1093/hmg/ddaa091

Sebire NJ and Vujanic GM. Paediatric renal tumours: recent developments, new entities and pathological features. Histopathology. 2009 Apr;54(5):516-28. https://doi.org/10.1111/j.1365-2559.2008.03110.x

Davidoff AM. Wilms Tumor. Adv Pediatr. 2012;59(1):247-67. doi: 10.1097/MOP.0b013e32832b323a

Charlton J, Irtan S, Bergeron C and Pritchard-Jones K. Bilateral Wilms tumour: a review of clinical and molecular features. Expert Rev Mol Med. 2017;19:8.

doi: https://doi.org/10.1017/erm.2017.8

Pater L, Melchior P and Rube C. Wilms tumor. Pediatr Blood Cancer. 2021;68:(2):28257.

Vujanić GM and Sandstedt B. The pathology of Wilms’ tumour (WT): the International Society of Paediatric Oncology approach. J Clin Pathol 2010; 63(2):102-9

http://dx.doi.org/10.1136/jcp.2009.064600

Lopes RI and Lorenzo A. Recent advances in the management of Wilms' tumor. F1000Res. 2017;6:670.

Metzger M and Dome J. Current Therapy for Wilms Tumor.Pediatr. Oncol.2005;10: 815-26 https://doi.org/10.1634/theoncologist.10-10-815

Godzinski J. The current status of treatment of Wilms’ tumor as per the SIOP trials. Journal of Indian Association of Pediatric Surgeons. 2015 Jan;20(1):16. doi: 10.4103/0971-9261.145439

Vujanić GM, Gessler M and Ooms AH. The Umbrella SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol. Nature reviews Urology. 2018 Nov;15(11):693-701. https://doi.org/10.1038/s41585-018-0100-3

Yousaf A, Mahmood S and Faraz R.Annual Cancer Registry Report-2018, of The Shaukat Khanum Memorial Cancer Hospital & Research Center, Pakistan. 2018, 1-21.

Guruprasad B, Rohan B and Kavitha S. Wilms’Tumor: Single Centre Retrospective Study from South India Indian J SurgOncol 2013; 4(3):301-304. https://doi.org/10.1007/s13193-013-0248-5

Faranoush M, Bahoush GR and Mehrvar A. Wilm’s tumor: Epidemiology and Survival. Research Journal of Biological Sciences 2009; 4 (1): 86-89.

Mazumder M, Islam A, Farooq N and Zaman M. Clinicopathological Profile of Wilms’ Tumour in Children. J Bangladesh Coll PhysSurg 2014;32:5-8 DOI: https://doi.org/10.3329/jbcps.v32i1.21015

Yao W, Li K, Xiao X, Gao J, Dong K and Xiao X. Outcomes of Wilms’ tumor in eastern China: 10 years of experience at a single center. Journal of Investigative Surgery. 2012 May 22;25(3):181-5. https://doi.org/10.3109/08941939.2011.615893

Stones DK, Hadley GP and Wainwright RD. The impact of ethnicity on Wilms tumor: characteristics and outcome of a South African cohort. International journal of pediatrics. 2015 Mar 26;2015 https://doi.org/10.1155/2015/706058

Anwar S, Faizan M and Khan S. A Five Year Experience of Wilms Tumor at a tertiary care centre, where we stand, a developing country perspective. P J M H S 2017; 11(4):1263-6. http://173.208.131.244:9060/xmlui/handle/123456789/13138

Ghafoor T, Bashir F and Ahmed S. Predictors of treatment outcome of Wilms Tumour in low-income country; single centre experience from Pakistan. Journal of pediatric urology. 2020 Jun 1;16(3):375-e1. https://doi.org/10.1016/j.jpurol.2020.03.001

Sayed H, Ali A and Hamza H. Long-term Follow-up of Infantile Wilms Tumor Treated According to International Society of Pediatric Oncology Protocol: Seven Years’ Follow-up. Urology 2011; 77(2):446-5. https://doi.org/10.1016/j.urology.2010.05.049

Verschuur AC, Vujanic GM, and Van Tinteren H. Stromal and epithelial predominant Wilms tumours have an excellent outcome: the SIOP 93 01 experience. Pediatric blood & cancer. 2010 Aug;55(2):233-8. https://doi.org/10.1002/pbc.22496

Shende A and Sathe PA. Clinicopathologic analysis of Wilms’ tumor – A retrospective study of 35 cases over 10 years. Ann Pathol Lab Med. 2018; 5(2):A151-157.

Taqiya Nuzhath and Prema Saldanha. Histopathological study of kidney tumors in children October 2016; 3(10): 880-883.

Pianezza ML, Rubin S and Bass J. Wilms tumor at the Children’s Hospital of Eastern Ontario. Can J Urol. 2004, 11: 2151-6.

Vujanić GM and D'Hooghe E. The effect of preoperative chemotherapy on histological subtyping and staging of Wilms tumors: The United Kingdom Children's Cancer Study Group (UKCCSG) Wilms tumor trial 3 (UKW3) experience. Pediatr Blood Cancer. 2019; 66(3):27549. https://doi.org/10.1002/pbc.27549

Vujanić GM, Kelsey A and Mitchell C. The role of biopsy in the diagnosis of renal tumors of childhood: Results of the UKCCSG Wilms Tumor Study 3. Med PediatrOncol 2003; 40(1):18-22. https://doi.org/10.1002/mpo.10216

Das RN, Chatterjee U and Sinha SK. Study of histopathological features and proliferation markers in cases of Wilms’ tumor. Indian journal of medical and paediatric oncology: official journal of Indian Society of Medical & Paediatric Oncology. 2012 Apr;33(2):102. DOI: 10.4103/0971-5851.99744

Hung IJ and Yang CP. Epidemiology, clinical feature and treatment outcome of Wilms’ Tumor in Taiwan: a report from Taiwan pediatric oncology group. J Formos Med Assoc, 2004; 103:104-11. PMID: 15083240

Eibrink MM, Grundy P and Graf N. Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: a collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups. Pediatric blood & cancer. 2008 Jun;50(6):1130-4. https://doi.org/10.1002/pbc.21389

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyright (c) 2023 Alia Ahmad, Aysha Anjum, Imran Hashim, Amber Goraya, Farrakh Mehmood Satar, Fariha Sahrish